Patents by Inventor Aman Beri

Aman Beri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12721814
    Abstract: A polarity-specific, multi-route delivery system for dietary supplement bioactives with each active pre-mapped to an optimized carrier tailored for oral, transdermal, or topical delivery. A unified formulation stability framework incorporates antioxidants, photoprotectants, oxygen scavengers, and nitrogen-flushed packaging, ensuring integrity under ICH Q1A(R2) conditions. The system supports modular formulations combining esterified DHEA analogs with adaptogens, minerals, amino acids, polyphenols, fatty acids, and vitamins, including coordinated oral-dermal or oral-transdermal regimens. Embodiments demonstrate enhanced nutrient bioavailability, reduced dosing frequency, and multi-phasic nutritional support for anabolic, metabolic, cognitive, cardiovascular, and healthy aging outcomes.
    Type: Grant
    Filed: November 17, 2025
    Date of Patent: September 1, 2026
    Assignee: AMERICANA PHARMA LLC
    Inventor: Aman Beri
  • Publication number: 20260158042
    Abstract: A method of forming a DHEA derivative supplement including adaptogens, modified stilbenoids complex, non-esterified omega-3 fatty acids, essential amino acids, HMB free acid, vitamins, L-arginine, creatine, green tea extracts, and chelated minerals, in a multi-bioavailability delivery system, based on the nature of the constituents, formed as an encapsulated micronized material having a phytosomal delivery system which reduces supplements dosage while increasing active nutrients efficacy and bioavailability by providing a targeted delivery system for nutritional effects.
    Type: Application
    Filed: October 22, 2025
    Publication date: June 11, 2026
    Applicant: Americana Pharma LLC
    Inventor: Aman Beri
  • Publication number: 20260157968
    Abstract: A polarity-specific, multi-route delivery system for dietary supplement bioactives with each active pre-mapped to an optimized carrier tailored for oral, transdermal, or topical delivery. A unified formulation stability framework incorporates antioxidants, photoprotectants, oxygen scavengers, and nitrogen-flushed packaging, ensuring integrity under ICH Q1A(R2) conditions. The system supports modular formulations combining esterified DHEA analogs with adaptogens, minerals, amino acids, polyphenols, fatty acids, and vitamins, including coordinated oral-dermal or oral-transdermal regimens. Embodiments demonstrate enhanced nutrient bioavailability, reduced dosing frequency, and multi-phasic nutritional support for anabolic, metabolic, cognitive, cardiovascular, and healthy aging outcomes.
    Type: Application
    Filed: November 17, 2025
    Publication date: June 11, 2026
    Applicant: Americana Pharma LLC
    Inventor: Aman Beri
  • Patent number: 12472188
    Abstract: A method of forming a DHEA derivative supplement including adaptogens, modified stilbenoids complex, non-esterified omega-3 fatty acids, essential amino acids, HMB free acid, vitamins, L-arginine, creatine, green tea extracts, and chelated minerals, in a multi-bioavailability delivery system, based on the nature of the constituents, formed as an encapsulated micronized material having a phytosomal delivery system which reduces supplements dosage while increasing active nutrients efficacy and bioavailability by providing a targeted delivery system for nutritional effects.
    Type: Grant
    Filed: December 11, 2024
    Date of Patent: November 18, 2025
    Assignee: AMERICANA PHARMA LLC
    Inventor: Aman Beri